Takehito Asakawa Selected Research

ikarugamycin

9/2021

A potent endocytosis inhibitor Ikarugamycin up-regulates TNF production.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Takehito Asakawa Research Topics

Disease

2	Neoplasms (Cancer) 12/2023 - 09/2021
2	Colitis 01/2023 - 01/2021
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2023 - 01/2021
1	Hepatocellular Carcinoma (Hepatoma) 12/2023
1	Hypersensitivity (Allergy) 01/2021
1	Inflammation (Inflammations) 01/2021

Drug/Important Bio-Agent (IBA)

1	atezolizumabIBA 12/2023
1	Bevacizumab (Avastin)FDA Link 12/2023
1	C-Reactive ProteinIBA 12/2023
1	LigandsIBA 01/2023
1	Dextran SulfateIBA 01/2023
1	CytokinesIBA 01/2023
1	ApelinIBA 01/2023
1	ikarugamycinIBA 09/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 09/2021
1	ClathrinIBA 09/2021
1	NickelIBA 01/2021
1	Serine (L-Serine)FDA Link 01/2021
1	Amino Acids FDA Link 01/2021

Therapy/Procedure

1	Therapeutics 12/2023
1	Oral Administration 01/2021